| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86086 |
HPPH-17偶联水溶性Gd(III)-氨乙基酰胺基-DOTA |
103 |
zcy |
2024-11-22 |
| 86087 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-环糊精 |
92 |
WYQ |
2024-11-22 |
| 86088 |
DOTA-CH2-Ph-azide(HCl salt) |
65 |
wyh |
2024-11-22 |
| 86089 |
204318-14-9,Edotreotide ,DOTA-TOC,DOTA-(酪氨酸3)-奥曲肽 |
93 |
kx |
2024-11-22 |
| 86090 |
CAS：911197-00-7 Propargyl-DOTA-tris(tBu)ester |
95 |
zyl |
2024-11-22 |
| 86091 |
罗丹明B,1-O-丙炔基-2,3,4,6-四-O-乙酰基-β-D-葡萄糖苷 |
106 |
WYQ |
2024-11-22 |
| 86092 |
DOTA-UAMC1110 DOTA螯合剂偶联FAP抑制剂(UAMC1110) |
129 |
zcy |
2024-11-22 |
| 86093 |
1-(1,3-二苯基-2-丙炔基)-哌啶 |
98 |
WYQ |
2024-11-22 |
| 86094 |
p-SCN-Bn-DOTA；127985-74-4 |
86 |
wyh |
2024-11-22 |
| 86095 |
(S)-5-氯-α-环丙炔基-2-氨基-α-三氟甲基苯甲醇 |
123 |
WYQ |
2024-11-22 |
| 86096 |
DOTA-NHS ester,四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
96 |
kx |
2024-11-22 |
| 86097 |
cas:149819-85-2 Iron DOTA Sodium Salt |
89 |
zyl |
2024-11-22 |
| 86098 |
Maleimide-DOTA ；1006711-90-5 |
92 |
wyh |
2024-11-22 |
| 86099 |
Cy3标记的血清聚糖 齐岳定制 |
78 |
zcy |
2024-11-22 |
| 86100 |
DOTA-tris (t-Bu ester) |
102 |
kx |
2024-11-22 |
| 86101 |
Dota-Eb-Tate Dota偶联生长抑素类似物 |
111 |
zcy |
2024-11-22 |
| 86102 |
2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) ；173308-19-5 |
90 |
wyh |
2024-11-22 |
| 86103 |
DOTA-TRI(ACID)-酰胺-三聚乙二醇-溴乙酰胺 |
86 |
zyl |
2024-11-22 |
| 86104 |
DOTA mono-NHS ester |
97 |
kx |
2024-11-22 |
| 86105 |
DOTA-Peptide 2 DOTA螯合多肽 |
90 |
zcy |
2024-11-22 |
| 86106 |
DOTA-peg-TAT ；大环配体-聚乙二醇- 穿膜肽 |
93 |
wyh |
2024-11-22 |
| 86107 |
cas:250612-06-7 DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 |
112 |
wyh |
2024-11-22 |
| 86108 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2 |
113 |
kx |
2024-11-22 |
| 86109 |
NHS偶联的DOTA螯合剂 DOTA-NHS |
258 |
zcy |
2024-11-22 |
| 86110 |
DOTA-三(酸) - 酰氨基-DPEG(R)12-TFP酯 |
119 |
zyl |
2024-11-22 |
| 86111 |
Ga-68 DOTA-TATE，镓-68标记的生长抑素类似物DOTA-TATE |
621 |
wyh |
2024-11-22 |
| 86112 |
Gd-EOB-DTPA的结构组成 |
287 |
kx |
2024-11-22 |
| 86113 |
DOTA-TRIS(TBE)-AMIDO-DPEG(R)12-TFP酯 |
113 |
zyl |
2024-11-22 |
| 86114 |
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) ；479081-06-6 |
102 |
wyh |
2024-11-22 |
| 86115 |
CAS:2125661-62-1 BUTYNE-DOTA 炔基 双功能螯合剂 |
169 |
zyl |
2024-11-22 |
| 86116 |
619300-53-7,DOTA多肽分子探针,DOTA NOC acetate |
98 |
kx |
2024-11-22 |
| 86117 |
p-NCS-Bz-DOTA-GA |
109 |
wyh |
2024-11-22 |
| 86118 |
Lysine-DOTA CAS号:508172-24-5 |
88 |
zyl |
2024-11-22 |
| 86119 |
5-Gd-DOTA-CS的组成与结构、功能与应用 |
118 |
kx |
2024-11-22 |
| 86120 |
CAS：1670260-54-4 DOTA-tris(t-Bu)-Amido-PEG7-Azide |
95 |
zyl |
2024-11-22 |
| 86121 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸；137076-54-1 |
91 |
wyh |
2024-11-22 |
| 86122 |
cas:1823122-52-6 ；DOTA-NHS-ester TFA |
124 |
wyh |
2024-11-22 |
| 86123 |
四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
107 |
kx |
2024-11-22 |
| 86124 |
DOTA-Acrylamide,DOTA-丙烯酰胺,双功能螯合剂 |
102 |
zyl |
2024-11-22 |
| 86125 |
cas: 819869-77-7；DOTA-tris(tBu)ester NHS ester |
107 |
wyh |
2024-11-22 |
| 86126 |
Ga-DOTA-FAPI/ANCP-PSMA ，镓-大环配体-蛋白抑制剂 |
239 |
kx |
2024-11-22 |
| 86127 |
DOTA-Octreotide，DOTATATE |
123 |
wyh |
2024-11-22 |
| 86128 |
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA (TFA salt) |
135 |
wyh |
2024-11-22 |
| 86129 |
(N3-PEG4)-(DOTA)-3K的基本组成 |
131 |
wyh |
2024-11-22 |
| 86130 |
909024-55-1,DOTA-cyclo(RGDfK) acetate |
110 |
kx |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询